Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Carcinoma, Neuroendocrine × Methods × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 36 Neoplasms 30 Lung Neoplasms 22 Colorectal Neoplasms 20 Uterine Cervical Neoplasms 12 Prostatic Neoplasms 11 Motor Activity 10 Colonic Neoplasms 9 Anxiety Disorders 8 Rectal Neoplasms 7 Pancreatic Neoplasms 7 Obesity 7 Carcinoma, Non-Small-Cell Lung 7 Lymphoma 6 Endometrial Neoplasms 6 Depression 6 Breast Carcinoma In Situ 6 Vulvar Neoplasms 5 Hematologic Neoplasms 5 Urinary Bladder Neoplasms 4 Pain 4 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Melanoma 4 Leukemia, Myeloid, Acute 4 Head and Neck Neoplasms 4 Fatigue 4 Carcinoma, Ovarian Epithelial 4 Vaginal Neoplasms 3 Triple Negative Breast Neoplasms 3

Interventions

Magnetic Resonance Imaging 2 gallium Ga 68 dotatate 1 Radiotherapy 1 Radiosurgery 1 Positron Emission Tomography Computed Tomography 1 Methods 1 Lansoprazole 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04478175 2022-11-17

DParcoursDig

Institut Curie

Phase NA Completed

Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡